-61% Off

Dasacad 50 mg Tablet

Original price was: ₹5,962.00.Current price is: ₹2,300.00.

Dasacad 50mg Tablet is used to treat chronic myeloid leukemia. It comes in when other treatments do not work well.

Product Details

Salt/Formula: Dasatinib (50mg)

Manufacturer: CADILA PHARMACEUTICALS LTD

Dosage: 50mg

Doctor's Prescription Required for this Product.

Out of stock

Benefits

The Dasacad 50mg Tablet is used to treat leukemia.

It does this by blocking the growth and spread of cancer cells.

This drug is powerful, but it can also be quite toxic.

You need to go over the possible risks with your doctor.

Try to avoid drinking alcohol while taking it.

Staying well hydrated is important too.

How to Use

Follow your doctor’s exact instructions when taking Dasacad 50mg Tablet. Stick to the prescribed dose and the recommended duration for it.

Specification

Follow your doctor’s exact instructions when taking Dasacad 50mg Tablet. Stick to the prescribed dose and the recommended duration for it.

Side Effects

Most side effects turn out to be mild in nature. They tend to fade away as your body gets accustomed to the treatment. Still, it makes sense to check with your doctor if any of them stick around or start getting worse.

Things like abdominal pain can show up.

Anemia, which involves low red blood cells, is another possibility.

Breathing problems might occur too.

Fatigue often comes along with it.

Fever is pretty common.

Headaches can hit as well.

Infections are something to watch for.

Low blood platelets represent a risk.

Bone, muscle, or joint pain might develop over time.

Nausea tends to be frequent.

Rash could appear on the skin.

Vomiting rounds out the list.

Description

The Dasacad 50mg Tablet is meant for treating chronic myeloid leukemia. It gets used in situations where other kinds of treatments just are not suitable.

Reviews

There are no reviews yet.

Be the first to review “Dasacad 50 mg Tablet”

Your email address will not be published. Required fields are marked *

You may also like…